BCR-ABL1 p190(mbcr) Detection Kit
£1,274.00
The BCR-ABL1 p190(mbcr) Detection Kit is designed for the fast and accurate detection of the BCR-ABL1 p190 fusion transcript, commonly associated with leukemia, using one-step RT-qPCR technology. This kit offers superior analytical sensitivity, achieving a Log4 reduction, and employs multiplex PCR for accurate relative quantitation of fusion transcripts against ABL1. Compatible with FAM and VIC/HEX dual-color real-time PCR instruments and CE-IVD certified, it is a crucial tool for diagnosing and monitoring leukemia by identifying one of its significant genetic markers.
The BCR-ABL1 p190(mbcr) Detection Kit is designed for the fast and accurate detection of the BCR-ABL1 p190 fusion transcript, commonly associated with leukemia, using one-step RT-qPCR technology. This kit offers superior analytical sensitivity, achieving a Log4 reduction, and employs multiplex PCR for accurate relative quantitation of fusion transcripts against ABL1. Compatible with FAM and VIC/HEX dual-color real-time PCR instruments and CE-IVD certified, it is a crucial tool for diagnosing and monitoring leukemia by identifying one of its significant genetic markers.
- Superior Analytical Sensitivity: Achieves a Log4 reduction, providing high sensitivity in detecting the BCR-ABL1 p190 fusion transcript.
- One-Step RT-qPCR Technology: Simplifies the testing process, making it fast and easy to use while ensuring precise results.
- Accurate Relative Quantitation: Utilizes multiplex PCR to quantify fusion transcripts relative to ABL1, enhancing diagnostic accuracy.
- Compatibility: Works with FAM and VIC/HEX dual-color real-time PCR instruments, offering broad applicability.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring reliability and quality.
- Efficient Diagnosis and Monitoring: Facilitates the rapid and accurate detection of BCR-ABL1 p190, crucial for diagnosing leukemia and monitoring treatment responses.
- Ease of Use: Streamlines the testing workflow, allowing for efficient processing of samples without sacrificing accuracy.
- Versatile Application: Can be utilized in various diagnostic settings thanks to its compatibility with commonly used real-time PCR platforms.
- Leukemia Diagnosis: Essential for identifying the BCR-ABL1 p190 fusion transcript, a key genetic marker in certain leukemia types.
- Treatment Monitoring: Plays a significant role in monitoring the effectiveness of leukemia treatments by quantifying the presence of the BCR-ABL1 p190 transcript over time.
- Technology: One-step RT-qPCR with multiplex PCR for relative quantitation of BCR-ABL1 fusion transcripts.
- Sensitivity: Superior analytical sensitivity with a Log4 reduction capability.
- Compatibility: Suitable for use with real-time PCR instruments capable of detecting FAM and VIC/HEX.
- Certification: CE-IVD marked, indicating its suitability for in vitro diagnostic use within the European Union.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
